Literature DB >> 20097901

FOXK2 transcription factor is a novel G/T-mismatch DNA binding protein.

Yoshito Fujii1, Michio Nakamura.   

Abstract

DNA mismatch repair is an important mechanism in the prevention of mutations. We reported the existence in the HL60 cell line of a novel G/T-mismatch DNA-binding protein (nGTBP) requiring strict DNA sequences. In this report, we identify the FOXK2 transcription factor as the nGTBP. FOXK2 fragments were obtained as the only clones with specifically binding activity to the G/T-mismatch DNA by screening of a human brain expression library. The recombinant forkhead domain of FOXK2 specifically recognized the G/T-mismatch DNA. The forkhead domain also recognized hypoxanthine/T and G/uracil, derived from the deamination of the exocyclic amino groups of A/T and G/C, respectively. An electrophoretic mobility shift assay (EMSA) analysis using HL60 cell nuclear extract and antibody raised against FOXK2 resulted in the exclusive binding of FOXK2 to G/T-mismatch DNA. Furthermore, FOXK2 bound to G/T-mismatch DNA with higher affinity than 'match' FOXK2 consensus DNA. We therefore propose that FOXK2 is a G/T-mismatch DNA-binding protein and a deaminated DNA-binding protein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20097901     DOI: 10.1093/jb/mvq004

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  8 in total

1.  The forkhead transcription factor FOXK2 promotes AP-1-mediated transcriptional regulation.

Authors:  Zongling Ji; Ian J Donaldson; Jingru Liu; Andrew Hayes; Leo A H Zeef; Andrew D Sharrocks
Journal:  Mol Cell Biol       Date:  2011-11-14       Impact factor: 4.272

2.  Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 study.

Authors:  Samantha Gadd; Vicki Huff; Andrew D Skol; Lindsay A Renfro; Conrad V Fernandez; Elizabeth A Mullen; Corbin D Jones; Katherine A Hoadley; Kai Lee Yap; Nilsa C Ramirez; Sheena Aris; Quy H Phung; Elizabeth J Perlman
Journal:  Cell Rep Med       Date:  2022-05-25

3.  FOXK2 transcription factor suppresses ERα-positive breast cancer cell growth through down-regulating the stability of ERα via mechanism involving BRCA1/BARD1.

Authors:  Ying Liu; Xiang Ao; Zhaojun Jia; Xiao-Yan Bai; Zhaowei Xu; Gaolei Hu; Xiao Jiang; Min Chen; Huijian Wu
Journal:  Sci Rep       Date:  2015-03-05       Impact factor: 4.379

4.  Forkhead box K2 inhibits the proliferation, migration, and invasion of human glioma cells and predicts a favorable prognosis.

Authors:  Bo Wang; XueBin Zhang; Wei Wang; ZhiZhong Zhu; Fan Tang; Dong Wang; Xi Liu; Hao Zhuang; XiaoLing Yan
Journal:  Onco Targets Ther       Date:  2018-02-27       Impact factor: 4.147

5.  FOXK2 promotes the proliferation of papillary thyroid cancer cell by down-regulating autophagy.

Authors:  Songze Li; Pengliang Wang; Hao Ju; Tiantong Zhu; Jingwen Shi; Ying Huang
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

6.  The forkhead transcription factor FOXK2 acts as a chromatin targeting factor for the BAP1-containing histone deubiquitinase complex.

Authors:  Zongling Ji; Hisham Mohammed; Aaron Webber; Jenna Ridsdale; Namshik Han; Jason S Carroll; Andrew D Sharrocks
Journal:  Nucleic Acids Res       Date:  2014-04-19       Impact factor: 16.971

7.  A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation.

Authors:  Mario Iurlaro; Gabriella Ficz; David Oxley; Eun-Ang Raiber; Martin Bachman; Michael J Booth; Simon Andrews; Shankar Balasubramanian; Wolf Reik
Journal:  Genome Biol       Date:  2013       Impact factor: 13.583

8.  BmILF and i-motif structure are involved in transcriptional regulation of BmPOUM2 in Bombyx mori.

Authors:  Kangkang Niu; Xiaojuan Zhang; Huimin Deng; Feng Wu; Yandong Ren; Hui Xiang; Sichun Zheng; Lin Liu; Lihua Huang; Baojuan Zeng; Sheng Li; Qingyou Xia; Qisheng Song; Subba Reddy Palli; Qili Feng
Journal:  Nucleic Acids Res       Date:  2018-02-28       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.